BLUE BELL, PA --- Wingspan Technology’s industry-leading eTMF now offers the ability for a user to browse any study in the TMF Reference Model Version 3 structure. The Reference Model browser allows a trial to be viewed in a tree structure based on the Reference Model zone, section and artifact. Any user can choose to view a study in this structure, even if it was created in an earlier version of the Reference Model or if the organization has modified the Reference Model to meet their requirements. A user can switch between this view and Wingspan’s powerful consumer-style filter navigation with a single click. The TMF Reference Model Browser provides a number of advantages over a traditional folder structure:
Clicking on any level will display a roll-up of all documents under that level. For example, clicking on the Safety Zone will show all documents across sections and artifact types within that zone. Traditional folder views would always show empty folders at the Zone and Section levels. The structure can be filtered to show specific countries and sites. As a result, it becomes much more usable than traditional folders in large studies with dozens of countries and hundreds of sites, which would otherwise result in hundreds of documents in each folder.
“Sponsors and who have committed to using the TMF Reference Model are now faced with the challenge of incorporating the best practice changes in the new Version 3,” said Kathie Clark, Wingspan’s Vice President of Product Management. “Wingspan’s TMF Reference Model browser means that they can upgrade their eTMF, even during an ongoing trial, and still see a unified presentation of a specific Trial Master File.”
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.